STT
27
-12
VZ
30
11
PFE
33
5
PLD
33
-13
BDX
44
-6
WEC
45
4
STX
48
2
NWSA
58
2
AFL
64
-5
ACN
43
5
AVY
44
-3
OKE
53
-6
VRTX
54
-4
SEE
32
2
BK
44
-2
GWW
57
-3
HST
45
-3
VMC
48
-3
GE
44
-2
RSG
40
-2
STT
27
-12
VZ
30
11
PFE
33
5
PLD
33
-13
BDX
44
-6
WEC
45
4
STX
48
2
NWSA
58
2
AFL
64
-5
ACN
43
5
AVY
44
-3
OKE
53
-6
VRTX
54
-4
SEE
32
2
BK
44
-2
GWW
57
-3
HST
45
-3
VMC
48
-3
GE
44
-2
RSG
40
-2
Financhill
Back

Taro Pharmaceutical Industries Quote, Financials, Valuation and Earnings

Introducing The Great $2 AI Moonshot

Open your free presentation now
Sell
32

TARO
Taro Pharmaceutical Industries

Last Price:
37.79
Seasonality Move:
3.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Wall Street Caliber A.I. for the "Little Guy"

Get the full story here

Taro Pharmaceutical Industries Price Quote

$37.79
+0.08 (+-0.08%)
(Updated: September 30, 2023 at 5:56 AM ET)

Taro Pharmaceutical Industries Key Stats

Sell
32
Taro Pharmaceutical Industries (TARO) is a Sell
Day range:
$37.55 - $37.94
52-week range:
$22.89 - $42.22
Dividend yield:
0%
P/E ratio:
55.46
P/S ratio:
2.39
P/B ratio:
0.82%
Volume:
19.3K
Avg. volume:
46.8K
1-year change:
31.21%
Market cap:
$1.4B
Revenue:
$573M
EPS:
$0.75

How Much Does Taro Pharmaceutical Industries Make?

Is Taro Pharmaceutical Industries Growing As A Company?

Taro Pharmaceutical Industries Stock Price Performance

What Is Taro Pharmaceutical Industries 52-Week High & Low?

Taro Pharmaceutical Industries Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Taro Pharmaceutical Industries?

Is Taro Pharmaceutical Industries Cash Flow Positive?

Data Unavailable

Taro Pharmaceutical Industries Return On Invested Capital

  • Is Management Doing A Good Job?
    TARO return on invested capital is 1.64%
  • What Is Taro Pharmaceutical Industries Return On Assets?
    ROA measures how assets are converting to revenues and is 1.32%
  • What Is TARO Return On Equity?
    ROE is a measure of profitability and is 1.64%

Taro Pharmaceutical Industries Earnings Date & Stock Price

Taro Pharmaceutical Industries Competitors

Taro Pharmaceutical Industries Dividend Yield

Data Unavailable

Taro Pharmaceutical Industries Analyst Estimates

YoY Growth Past Surprise
EPS: -63.01% 29.03%
Revenue: 10.91% 6.62%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 35.00
Downside from Last Price: -7.19%

Major Shareholders

  • How many TARO shares are owned by institutional investors?
    36.9M TARO shares are owned by institutional investors
  • How many TARO shares are owned by insiders?
    0 TARO shares are owned by insiders